Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun 19:36:100986.
doi: 10.1016/j.ymgmr.2023.100986. eCollection 2023 Sep.

Clinical and genetic characteristics of a patient with phosphoribosyl pyrophosphate synthetase 1 deficiency and a systematic literature review

Affiliations
Case Reports

Clinical and genetic characteristics of a patient with phosphoribosyl pyrophosphate synthetase 1 deficiency and a systematic literature review

Katarina Štajer et al. Mol Genet Metab Rep. .

Abstract

Phosphoribosylpyrophosphate synthetase 1 (PRS-I) is an enzyme involved in nucleotide metabolism. Pathogenic variants in the PRPS1 are rare and PRS-I deficiency can manifest as three clinical syndromes: X-linked non-syndromic sensorineural deafness (DFN2), X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5) and Arts syndrome. We present a Slovenian patient with PRS-I enzyme deficiency due to a novel pathogenic variant - c.424G > A (p.Val142Ile) in the PRPS1 gene, who presented with gross motor impairment, severe sensorineural deafness, balance issues, ataxia, and frequent respiratory infections. In addition, we report the findings of a systemic literature review of all described male cases of Arts syndrome and CMTX5 as well as intermediate phenotypes. As already proposed by other authors, our results confirm PRS-I deficiency should be viewed as a phenotypic continuum rather than three separate syndromes because there are multiple reports of patients with an intermediary clinical presentation.

Keywords: Arts syndrome; PRPS1; PRS-I deficiency; PRS-I super-activity; Phosphoribosylpyrophosphate synthetase 1; X-linked Charcot-Marie-Tooth neuropathy type 5.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram for systematic literature review.

Similar articles

References

    1. Almoguera B., et al. Expanding the phenotype of PRPS1 syndromes in females: neuropathy, hearing loss and retinopathy. Orphanet J. Rare Dis. 2014;9(1):190. doi: 10.1186/s13023-014-0190-9. - DOI - PMC - PubMed
    1. de Brouwer A.P.M., van Bokhoven H., Nabuurs S.B., Arts W.F., Christodoulou J., Duley J. PRPS1 mutations: four distinct syndromes and potential treatment. Am. J. Hum. Genet. 2010;86(4):506–518. doi: 10.1016/j.ajhg.2010.02.024. - DOI - PMC - PubMed
    1. Fiorentino A., et al. Missense variants in the X-linked gene PRPS1 cause retinal degeneration in females. Hum. Mutat. 2018;39(1):80–91. doi: 10.1002/humu.23349. - DOI - PubMed
    1. Mittal R., et al. Association of PRPS1 mutations with disease phenotypes. Dis. Markers. 2015;2015:1–7. doi: 10.1155/2015/127013. - DOI - PMC - PubMed
    1. Mercati O., et al. PRPS1 loss-of-function variants, from isolated hearing loss to severe congenital encephalopathy: New cases and literature review. Eur. J. Med. Genet. 2020;63(11) doi: 10.1016/j.ejmg.2020.104033. - DOI - PubMed

Publication types